4
Changes in Ownership
agilon health, inc. Filed Acc 0001209191-22-020015
Chief Strategy & Dev. Officer sold 197,291 shares at $20.41 ($4,026,709)
- Chief Strategy & Dev. Officer acquired 197,291 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Desai Veeral Chief Strategy & Dev. Officer | 2022-03-16 | Option exercise | +197,291 | $1.00 | $197,291 | 459,247 | D |
| Desai Veeral Chief Strategy & Dev. Officer | 2022-03-16 | Sale | −197,291 | $20.41 | $4,026,709 | 261,956 | D |
| Derivatives | |||||||
| Desai Veeral Chief Strategy & Dev. Officer | 2022-03-16 | Option exercise · Options (Right to buy) | −197,291 | 899,597 | D | ||
| Open-market sales · 197,291 sh · avg $20.41 · $4,026,709 | |||||||
Loading xslF345X03/doc4.xml…